Goodwin advised BeiGene, Ltd. in its follow-on public offering of 7,920,800 of its American Depositary Shares (the “ADSs”) at the public offering price of $101.00 per…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
